atropine has been researched along with 2-amino-5-phosphono-3-pentenoic acid in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (2-amino-5-phosphono-3-pentenoic acid) | Trials (2-amino-5-phosphono-3-pentenoic acid) | Recent Studies (post-2010) (2-amino-5-phosphono-3-pentenoic acid) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 27 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faria, LC; Fuortes, MG; Merlin, LR | 1 |
1 other study(ies) available for atropine and 2-amino-5-phosphono-3-pentenoic acid
Article | Year |
---|---|
Impact of protein kinase C activation on epileptiform activity in the hippocampal slice.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Action Potentials; Animals; Atropine; Benzoates; Benzophenanthridines; Enzyme Activation; Epilepsy; Glutamic Acid; Glycine; Guinea Pigs; Hippocampus; In Vitro Techniques; Neurotransmitter Agents; Phorbol 12,13-Dibutyrate; Picrotoxin; Protein Kinase C; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Signal Transduction | 2008 |